/Companies

Caradon Therapeutics

Encinitas, US · Founded 2023 · Delaware corporation

Find your way into Caradon Therapeutics

Sign up to see every warm intro you have to Caradon Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Caradon Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BL
Brian Laurence JohnsonExecutive

Reported raises · per SEC filings

Form D private placements

$559.3K disclosed across 1 round · 2026

▶$559.3KraisedFeb 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian Laurence JohnsonExecutive Officer, Director
Offering amount
$900K
Amount sold
$559.3K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Caradon Therapeutics raised?
Caradon Therapeutics has disclosed $559.3K raised across 1 round.
Where is Caradon Therapeutics headquartered?
Caradon Therapeutics is headquartered in Encinitas, US.